Recombinant Laminin-521


Ontology type: sgo:Patent     


Patent Info

DATE

2012-06-21T00:00

AUTHORS

TRYGGVASON, KARL , RODIN, SERGEY

ABSTRACT

The present disclosure related to isolated laminin-521, methods for making recombinant laminin-521, host cells that express recombinant laminin-521, and compositions containing laminin-521. Laminin-521 can maintain stem cells in vitro pluripotency, enable self-renewal, and enable single cell survival of human embryonic stem cells. When pluripotent human embryonic stem cells are cultured on plates coated with a matrix of recombinant laminin-521 (laminin 11), in the absence of differentiation inhibitors or feeder cells, the embryonic stem cells proliferate and maintain their pluripotency. It has also been discovered that human recombinant laminin-521 (laminin-11) provides single cell survival of stem cells after complete dissociation into a single cell suspension. Useful cell culture mediums containing at most 3.9 ng/ml of beta fibroblast growth factor (bFGF) are also described herein. More... »

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2581", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "name": "TRYGGVASON, KARL", 
        "type": "Person"
      }, 
      {
        "name": "RODIN, SERGEY", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1074/jbc.m111228200", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012337970"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.bbrc.2005.03.058", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021906730"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.bbrc.2005.03.058", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021906730"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nbt1177", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030407065", 
          "https://doi.org/10.1038/nbt1177"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nbt1177", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030407065", 
          "https://doi.org/10.1038/nbt1177"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1074/jbc.m809332200", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039005194"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2012-06-21T00:00", 
    "description": "

The present disclosure related to isolated laminin-521, methods for making recombinant laminin-521, host cells that express recombinant laminin-521, and compositions containing laminin-521. Laminin-521 can maintain stem cells in vitro pluripotency, enable self-renewal, and enable single cell survival of human embryonic stem cells. When pluripotent human embryonic stem cells are cultured on plates coated with a matrix of recombinant laminin-521 (laminin 11), in the absence of differentiation inhibitors or feeder cells, the embryonic stem cells proliferate and maintain their pluripotency. It has also been discovered that human recombinant laminin-521 (laminin-11) provides single cell survival of stem cells after complete dissociation into a single cell suspension. Useful cell culture mediums containing at most 3.9 ng/ml of beta fibroblast growth factor (bFGF) are also described herein.

", "id": "sg:patent.WO-2012080842-A1", "keywords": [ "laminin", "disclosure", "method", "host cell", "composition", "stem cell", "pluripotency", "cell survival", "human embryonic stem cell", "plate", "matrix", "absence", "inhibitor", "feeder cell", "embryonic stem cell", "single cell suspension", "cell culture medium", "fibroblast growth factor" ], "name": "RECOMBINANT LAMININ-521", "recipient": [ { "id": "https://www.grid.ac/institutes/grid.451737.3", "type": "Organization" } ], "sameAs": [ "https://app.dimensions.ai/details/patent/WO-2012080842-A1" ], "sdDataset": "patents", "sdDatePublished": "2019-04-18T10:09", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com-uberresearch-data-patents-target-20190320-rc/data/sn-export/402f166718b70575fb5d4ffe01f064d1/0000100128-0000352499/json_export_00357.jsonl", "type": "Patent" } ]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/patent.WO-2012080842-A1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/patent.WO-2012080842-A1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/patent.WO-2012080842-A1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/patent.WO-2012080842-A1'


 

This table displays all metadata directly associated to this object as RDF triples.

57 TRIPLES      15 PREDICATES      36 URIs      26 LITERALS      2 BLANK NODES

Subject Predicate Object
1 sg:patent.WO-2012080842-A1 schema:about anzsrc-for:2581
2 schema:author N3ab43dec237640ef8eed8adcbe8ced9e
3 schema:citation sg:pub.10.1038/nbt1177
4 https://doi.org/10.1016/j.bbrc.2005.03.058
5 https://doi.org/10.1074/jbc.m111228200
6 https://doi.org/10.1074/jbc.m809332200
7 schema:datePublished 2012-06-21T00:00
8 schema:description <p>The present disclosure related to isolated laminin-521, methods for making recombinant laminin-521, host cells that express recombinant laminin-521, and compositions containing laminin-521. Laminin-521 can maintain stem cells in vitro pluripotency, enable self-renewal, and enable single cell survival of human embryonic stem cells. When pluripotent human embryonic stem cells are cultured on plates coated with a matrix of recombinant laminin-521 (laminin 11), in the absence of differentiation inhibitors or feeder cells, the embryonic stem cells proliferate and maintain their pluripotency. It has also been discovered that human recombinant laminin-521 (laminin-11) provides single cell survival of stem cells after complete dissociation into a single cell suspension. Useful cell culture mediums containing at most 3.9 ng/ml of beta fibroblast growth factor (bFGF) are also described herein.</p>
9 schema:keywords absence
10 cell culture medium
11 cell survival
12 composition
13 disclosure
14 embryonic stem cell
15 feeder cell
16 fibroblast growth factor
17 host cell
18 human embryonic stem cell
19 inhibitor
20 laminin
21 matrix
22 method
23 plate
24 pluripotency
25 single cell suspension
26 stem cell
27 schema:name RECOMBINANT LAMININ-521
28 schema:recipient https://www.grid.ac/institutes/grid.451737.3
29 schema:sameAs https://app.dimensions.ai/details/patent/WO-2012080842-A1
30 schema:sdDatePublished 2019-04-18T10:09
31 schema:sdLicense https://scigraph.springernature.com/explorer/license/
32 schema:sdPublisher N42a1eb292a794e40ab2597fa1b18dd34
33 sgo:license sg:explorer/license/
34 sgo:sdDataset patents
35 rdf:type sgo:Patent
36 N08b0946ef6494a868b961aff1e274222 schema:name TRYGGVASON, KARL
37 rdf:type schema:Person
38 N3ab43dec237640ef8eed8adcbe8ced9e rdf:first N08b0946ef6494a868b961aff1e274222
39 rdf:rest Nbc7cb83bd9884160904dcbfca06b3247
40 N42a1eb292a794e40ab2597fa1b18dd34 schema:name Springer Nature - SN SciGraph project
41 rdf:type schema:Organization
42 N83aa7aa37fae48a68885f2f67a28ca0f schema:name RODIN, SERGEY
43 rdf:type schema:Person
44 Nbc7cb83bd9884160904dcbfca06b3247 rdf:first N83aa7aa37fae48a68885f2f67a28ca0f
45 rdf:rest rdf:nil
46 anzsrc-for:2581 schema:inDefinedTermSet anzsrc-for:
47 rdf:type schema:DefinedTerm
48 sg:pub.10.1038/nbt1177 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030407065
49 https://doi.org/10.1038/nbt1177
50 rdf:type schema:CreativeWork
51 https://doi.org/10.1016/j.bbrc.2005.03.058 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021906730
52 rdf:type schema:CreativeWork
53 https://doi.org/10.1074/jbc.m111228200 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012337970
54 rdf:type schema:CreativeWork
55 https://doi.org/10.1074/jbc.m809332200 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039005194
56 rdf:type schema:CreativeWork
57 https://www.grid.ac/institutes/grid.451737.3 schema:Organization
 




Preview window. Press ESC to close (or click here)


...